Botanix Pharmaceuticals Limited
BXPHF
$0.25
$0.000.00%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -25.94M | -17.66M | -9.10M | -7.86M | -6.65M |
| Total Depreciation and Amortization | 781.10K | 419.50K | 47.70K | 57.90K | 68.80K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.25M | 2.06M | 2.88M | 2.89M | 2.91M |
| Change in Net Operating Assets | 840.50K | 840.50K | 840.50K | -1.10M | -3.08M |
| Cash from Operations | -23.07M | -14.34M | -5.33M | -6.01M | -6.74M |
| Capital Expenditure | -110.20K | -92.50K | -74.00K | -49.70K | -25.40K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -2.58M | -7.13M | -11.70M | -11.31M | -10.94M |
| Cash from Investing | -2.69M | -7.22M | -11.77M | -11.36M | -10.96M |
| Total Debt Issued | -- | -- | -- | 0.00 | 0.00 |
| Total Debt Repaid | -61.60K | -30.80K | -- | -16.20K | -32.40K |
| Issuance of Common Stock | 72.98M | 86.92M | 100.86M | 69.66M | 38.47M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -4.18M | -4.97M | -5.76M | -3.97M | -2.19M |
| Cash from Financing | 45.25M | 53.84M | 62.47M | 43.12M | 23.89M |
| Foreign Exchange rate Adjustments | 256.00K | 157.50K | 57.50K | 89.50K | 124.20K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | 0.00 | 0.00 |
| Net Change in Cash | 19.75M | 32.44M | 45.42M | 25.84M | 6.30M |
